Mandate

Vinge advises the founders of Modular Finance in connection with a transaction with Sprints

Vinge advises the founders of Modular Finance in connection with a sale of approximately 40% of the shares in the company to Sprints.

Modular Finance is a SaaS company focusing on the financial markets in the Nordics and the United Kingdom. Through two business areas, Banking & Finance and Investor Relations, a range of niche products is offered with a focus on unique data sets and user-friendliness.

Sprints has a team founded and led by Swedes but headquartered in the UK, and is a focused investor in tech-enabled companies with prior experience as investors in Hemnet and existing investments in companies such as Teamtailor, Planhat, Vinted and Revolut.

The company’s founders Måns Flodberg, Rasmus Holm and Petter Hedborg will retain the majority of their shares and will remain fully involved over the coming years. Rite Ventures which has been a partner since 2014 will also keep the majority of their shares.

Vinge’s team consisted of partners Christina Kokko and Karl Klackenberg together with Viktor Lennartsson, Egil Svensson and Gustav Persson (M&A), Victor Ericsson and Morgan Ödman (Tax), and Daniel Wendelsson (Regulatory).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025